Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Bichet

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Journal of the American Society of Nephrology : JASN|April 12, 2014
A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresisWiebke Kristin Fenske, Mirjam Christ-Crain, Anna Hörning, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
American Journal of Physiology. Renal Physiology|May 22, 2009
Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotypeCécile Guyon, Yoann Lussier, Pierre Bissonnette, et al.
Physiological Reports|June 13, 2021
Further evidence for functional recovery of AQP2 mutations associated with nephrogenic diabetes insipidusPierre Bissonnette, Yoann Lussier, Jessica Matar, et al.
The Journal of Cell Biology|December 10, 2003
Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidusErik-Jan Kamsteeg, Daniel G Bichet, Irene B M Konings, et al.
Journal of the American Society of Nephrology : JASN|June 12, 2016
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2Michael J Coady, Abdulah El Tarazi, René Santer, et al.
Journal of the American Society of Nephrology : JASN|December 2, 2005
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidusVirginie Bernier, Jean-Pierre Morello, Alexandro Zarruk, et al.
Journal of Medical Genetics|March 13, 2020
Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroupDominique P Germain, João Paulo Oliveira, Daniel G Bichet, et al.
Human Molecular Genetics|April 4, 2002
Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidusNannette Marr, Daniel G Bichet, Michele Lonergan, et al.
Nephron. Physiology|December 5, 2012
Response of the renal inner medulla to hypoxia: possible defense mechanismsNamhee Kim, Laura Voicu, Gregory M T Hare, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Journal of the American Society of Nephrology : JASN|April 12, 2014
A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresisWiebke Kristin Fenske, Mirjam Christ-Crain, Anna Hörning, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
American Journal of Physiology. Renal Physiology|May 22, 2009
Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotypeCécile Guyon, Yoann Lussier, Pierre Bissonnette, et al.
Physiological Reports|June 13, 2021
Further evidence for functional recovery of AQP2 mutations associated with nephrogenic diabetes insipidusPierre Bissonnette, Yoann Lussier, Jessica Matar, et al.
The Journal of Cell Biology|December 10, 2003
Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidusErik-Jan Kamsteeg, Daniel G Bichet, Irene B M Konings, et al.
Journal of the American Society of Nephrology : JASN|June 12, 2016
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2Michael J Coady, Abdulah El Tarazi, René Santer, et al.
Journal of the American Society of Nephrology : JASN|December 2, 2005
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidusVirginie Bernier, Jean-Pierre Morello, Alexandro Zarruk, et al.
Journal of Medical Genetics|March 13, 2020
Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroupDominique P Germain, João Paulo Oliveira, Daniel G Bichet, et al.
Human Molecular Genetics|April 4, 2002
Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidusNannette Marr, Daniel G Bichet, Michele Lonergan, et al.
Nephron. Physiology|December 5, 2012
Response of the renal inner medulla to hypoxia: possible defense mechanismsNamhee Kim, Laura Voicu, Gregory M T Hare, et al.
Pageof 15